| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |